Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexamethasone and postoperative infection trial
NL-OMON47052Phase 4Withdrawn
- Sponsor
- Alfred Health
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative nausea and vomiting (PONV) comparing Dexamethasone with Saline placebo (2 arms). Primary endpoint: Surgical site infection at 30 days. Planned start Jul 2018; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NL-OMON47052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47052.